Defymed is a startup based in France, 1 tracked investor.
Defymed is a company headquartered in France. Brouky records 1 investor associated with the company.
Defymed is a medical device company developing innovative implantable devices for the treatment of Type 1 diabetes. Their Mailpan® technology protects insulin-producing cells from immune system destruction.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.